The identification of TNFR5 as a therapeutic target in diabetes

Expert Opinion on Therapeutic Targets

Volumn 21, Issue 4, 2017, Pages 349-351

  Turner, Mark D ^a  

^a NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

Author keywords

Biologics; diabetogenesis; islet cell death; phage display

Indexed keywords

TUMOR NECROSIS FACTOR ANTIBODY; ANTIDIABETIC AGENT; CD40 ANTIGEN;

ANTIBODY AFFINITY; DIABETES MELLITUS; DRUG REPOSITIONING; EDITORIAL; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PHAGE DISPLAY; TREATMENT OUTCOME; IMMUNOLOGY; PATHOLOGY; PATHOPHYSIOLOGY;

CD40 ANTIGENS; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN-SECRETING CELLS;

EID: 85014512058     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1080/14728222.2017.1297426     Document Type: Editorial

References (17)

1. Mathis D, Vence L, Benoist C., beta-Cell death during progression to diabetes. Nature. 2001;414:792–798.
2. Rhodes CJ. Type 2 diabetes–a matter of beta-cell life and death? Science. 2005;307:380–384.
3. Tataranni PA, Ortega E. A burning question:does an adipokine-induced activation of the immune system mediate the effect of overnutrition on type 2 diabetes? Diabetes. 2005;54:917–927.• Link between metabolic stress, obesity, and pro-inflammatory cytokine signaling in type 2 diabetes (T2D) pathophysiology.
4. Bagnati M, Ogunkolade BW, Marshall C, et al. Glucolipotoxicity initiates pancreatic β-cell death through TNFR5/CD40 mediated STAT1 and NF-κB activation. Cell Death Dis. 2016;7:e2329.•• First demonstration of the prevention of glucose- and fatty-acid-mediated induction of pancreatic β-cell inflammation through targeted inhibition of TNFR5 signaling.
5. Donath MY, Boni-Schnetzler M, Ellingsgaard H, et al. Islet inflammation impairs the pancreatic β-cell in type 2 diabetes. Physiology. 2009;24:325–331.• Rationale for T2D as an auto-inflammatory disease, with proposed therapeutic intervention strategies that target cytokine signaling.
6. Novotny GW, Lundh M, Backe MB, et al. Transcriptional and translational regulation of cytokine signaling in inflammatory β-cell dysfunction and apoptosis. Arch Biochem Biophys. 2012;528:171–184.
7. Moore F, Naamane N, Colli ML, et al. STAT1 is a master regulator of pancreatic β-cell apoptosis and islet inflammation. J Biol Chem. 2011;286:929–941.
8. Kirk AD, Knechtle SJ, Vincenti FG, et al. Preliminary results of the use of humanized anti-CD154 in human renal allotransplantation. Am J Transpl. 2001;1(suppl 1):191.
9. Boumpas DT, Furie R, Manzi S, et al.; BG9588 Lupus Nephritis Trial Group. Short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis. Arthritis Rheum. 2003;48:719–727.
10. Sidiropoulos PI, Boumpas DT. Lessons learned from anti-CD40L treatment in systemic lupus erythematosus patients. Lupus. 2004;13:391–397.
11. Pree I, Wekerle T. New approaches to prevent transplant rejection:co-stimulation blockers anti-CD40L and CTLA4Ig. Drug Discov Today. 2006;3:41–47.
12. Porter RR. The hydrolysis of rabbit y-globulin and antibodies with crystalline papain. Biochem J. 1959;73:119–126.
13. Nisonoff A, Wissler FC, Lipman LN. Properties of the major component of a peptic digest of rabbit antibody. Science. 1960;132:1770–1771.
14. Smith GP. Filamentous fusion phage:novel expression vectors that display cloned antigens on the virion surface. Science. 1985;228:1315–1317.
15. Barbas CF, Kang AS, Lerner RA, et al. Assembly of combinatorial antibody libraries on phage surfaces:the gene III site. Proc Natl Acad Sci U S A. 1991;88:7978–7982.
16. Huston JS, Levinson D, Mudgett-Hunter M, et al. Protein engineering of antibody binding sites:recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc Natl Acad Sci U S A. 1988;85:5879–5883.
17. Adams GP, Schier R, McCall AM, et al. Prolonged in vivo tumour retention of a human diabody targeting the extracellular domain of human HER2/neu. Brit J Cancer. 1998;77:1405–1412.